- Latest available (Revised)
- Original (As adopted by EU)
Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits,M — Factors | Notes | |||
---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
Acute Tox. 1 | H330 | Dgr | H330 | |||||||
Aquatic Acute 1 | H400 | H400 | ||||||||
015-005-00-3 | magnesium phosphide; trimagnesium diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
Acute Tox. 1 | H330 | Dgr | H330 | |||||||
Aquatic Acute 1 | H400 | H400 | ||||||||
015-123-00-5 | fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | H300 | GHS06 | H300 | M = 100 M = 100 | ||
Acute Tox. 2 | H310 | GHS09 | H310 | |||||||
Acute Tox. 2 | H330 | Dgr | H330 | |||||||
Eye Irrit. 2 | H319 | H319 | ||||||||
Aquatic Acute 1 | H400 | |||||||||
Aquatic Chronic 1 | H410 | H410 | ||||||||
030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | H413 | ||||
602-006-00-4 | chloroform; trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | H351 | GHS06 | H351 | |||
Repr. 2 | H361d | GHS08 | H361d | |||||||
Acute Tox. 3 | H331 | Dgr | H331 | |||||||
Acute Tox. 4 | H302 | H302 | ||||||||
STOT RE 1 | H372 | H372 | ||||||||
Eye Irrit. 2 | H319 | H319 | ||||||||
Skin Irrit. 2 | H315 | H315 | ||||||||
603-097-00-3 | 1,1’,1’-nitrilotripropan-2-ol; triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 Wng | H319 | |||
605-008-00-3 | acrolein; prop-2-enal; acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | EUH071 | Skin Corr. 1; H314: C ≥ 0,1 % | D |
Acute Tox. 1 | H330 | GHS06 | H330 | |||||||
Acute Tox. 2 | H300 | GHS05 | H300 | |||||||
Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
Skin Corr. 1 | H314 | Dgr | H314 | |||||||
Aquatic Acute 1 | H400 | M = 100 | ||||||||
Aquatic Chronic 1 | H410 | H410 | M = 1 | |||||||
607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | H225 | GHS02 | H225 | D | ||
Carc. 2 | H351 | GHS08 | H351 | |||||||
Acute Tox. 4 | H332 | GHS07 | H332 | |||||||
STOT SE 3 | H335 | Dgr | H335 | |||||||
607-613-00-8 | reaction mass of:
| 432-790-1 | Acute Tox. 4* | H332 | GHS07 | H332 | ||||
Acute Tox. 4* | H312 | GHS05 | H312 | |||||||
Acute Tox. 4* | H302 | GHS08 | H302 | |||||||
Skin Corr. 1B | H314 | Dgr | H314 | |||||||
STOT SE 2 | H371 (eyes) | H371 (eyes) | ||||||||
609-003-00-7 | nitrobenzene | 202-716-0 | 98-95-3 | Carc. 2. | H351 | GHS06 | H351 | |||
Repr. 1B | H360F | GHS08 | H360F | |||||||
Acute Tox. 3 | H301 | Dgr | H301 | |||||||
Acute Tox. 3 | H331 | H331 | ||||||||
Acute Tox. 3 | H311 | H311 | ||||||||
STOT RE 1 | H372 (blood) | H372 (blood) | ||||||||
Aquatic Chronic 3 | H412 | H412 | ||||||||
612-120-00-6 | aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline | 277-704-1 | 74070-46-5 | Carc. 2 | H351 | GHS08 | H351 | M = 100 M = 10 | ||
Skin Sens. 1A | H317 | GHS07 | H317 | |||||||
Aquatic Acute 1 | H400 | GHS09 | ||||||||
Aquatic Chronic 1 | H410 | Wng | H410 | |||||||
613-175-00-9 | epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane | 406-850-2 | 133855-98-8 | Carc. 2 | H351 | GHS08 | H351 | |||
Repr. 1B | H360Df | GHS09 | H360Df | |||||||
Aquatic Chronic 2 | H411 | Dgr | H411 | |||||||
616-200-00-1 | reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) | 432-430-3 | Aquatic Chronic 4 | H413 | H413 | |||||
648-055-00-5 | pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 266-028-2 | 65996-93-2 | Carc. 1A | H350 | GHS08 | H350 | M = 1000 M = 1000 | ||
Muta. 1B | H340 | GHS09 | H340 | |||||||
Repr. 1B | H360FD | Dgr | H360FD | |||||||
Aquatic Acute 1 | H400 | |||||||||
Aquatic Chronic 1 | H410 | H410 | ||||||||
649-330-00-2 | naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] | 265-185-4 | 64742-82-1 | Carc. 1B | H350 | GHS08 | H350 | P | ||
Muta. 1B | H340 | Dgr | H340 | |||||||
STOT RE 1 | H372 (central nervous system) | H372 (central nervous system) | ||||||||
Asp. Tox. 1 | H304 | H304 | ||||||||
649-345-00-4 | stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] | 232-489-3 | 8052-41-3 | Carc. 1B | H350 | GHS08 | H350 | P | ||
Muta. 1B | H340 | Dgr | H340 | |||||||
STOT RE 1 | H372 (central nervous system) | H372 (central nervous system) | ||||||||
Asp. Tox. 1 | H304 | H304 | ||||||||
649-405-00-X | solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] | 265-191-7 | 64742-88-7 | STOT RE 1 | H372 (central nervous system) | GHS08 | H372 (central nervous system) | |||
Asp. Tox. 1 | H304 | Dgr | H304 |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: